{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/breast-cancer-managing-fh/background-information/prevalence/","result":{"pageContext":{"chapter":{"id":"7d6fa54b-1dc8-5cbd-9bf4-6d9ac0dc26f0","slug":"prevalence","fullItemName":"Prevalence","depth":2,"htmlHeader":"<!-- begin field 3bf48849-88ad-420e-a8e8-9b08a5e838ba --><h2>How common is it?</h2><!-- end field 3bf48849-88ad-420e-a8e8-9b08a5e838ba -->","summary":"","htmlStringContent":"<!-- begin item 75b90bae-d17e-49bc-8888-81541c7504d3 --><!-- begin field 7ff02fa0-f7b8-4150-b905-30da6d83a770 --><ul><li><strong>Breast cancer is the most common cancer in the UK, accounting for 15% of all new cancer cases </strong>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/breast-cancer-managing-fh/references/\">Cancer Research UK, 2018b</a>]<strong>.</strong><ul><li>It is the most common cancer in women in the UK, accounting for nearly 1 in 3 (31%) of all new female cancer cases.</li><li>In 2015, there were 55,122 cases diagnosed in the UK (54,751 in females and 371 in males).</li><li>In the UK, the lifetime risk of developing breast cancer is about 15% (1 in 7) for women born after 1960 [<a class=\"bibliography-reference internal-reference\" href=\"/topics/breast-cancer-managing-fh/references/\">Cancer Research UK, 2018b</a>], and less than 0.1% for men [<a class=\"bibliography-reference internal-reference\" href=\"/topics/breast-cancer-managing-fh/references/\">National Collaborating Centre for Cancer, 2017</a>]. However [<a class=\"bibliography-reference internal-reference\" href=\"/topics/breast-cancer-managing-fh/references/\">National Collaborating Centre for Cancer, 2017</a>]:<ul><li>People with a family history of breast, ovarian, or a related cancer might have a higher lifetime risk than the general population. </li><li>The lifetime risk of breast cancer in women with a <a class=\"topic-reference internal-reference\" href=\"/topics/breast-cancer-managing-fh/background-information/genetic-risk-factors/\">gene mutation</a> is substantially increased compared to the general population.</li></ul></li></ul></li><li><strong>The incidence of breast cancer is strongly related to age, with the highest incidence rates being in older people. </strong>In the UK<strong> </strong>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/breast-cancer-managing-fh/references/\">Cancer Research UK, 2018b</a>]:<ul><li>In 2013–2015, on average each year 25% of new cases were in people aged 75 years and older.</li><li>Age-specific incidence rates rise steadily from around age 30–34 years and more steeply from around age 70–74 years. The highest rates are in women aged 85–89 years and in men aged over 90 years.</li><li>Incidence rates are significantly lower in men than women in a number of (mainly older) age groups. The gap is widest at age 45–49 years, when the age-specific incidence rate is 423 times lower in males than females.</li></ul></li><li><strong>Between 6–19% of women with breast cancer will have a family history of the disease</strong> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/breast-cancer-managing-fh/references/\">National Collaborating Centre for Cancer, 2017</a>]. </li><li><strong>Inherited mutations in specific <a class=\"topic-reference internal-reference\" href=\"/topics/breast-cancer-managing-fh/background-information/genetic-risk-factors/\">genes</a>, including BRCA1and BRCA2, account for about 5% of all breast cancer cases</strong> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/breast-cancer-managing-fh/references/\">National Collaborating Centre for Cancer, 2017</a>].</li></ul><!-- end field 7ff02fa0-f7b8-4150-b905-30da6d83a770 --><!-- end item 75b90bae-d17e-49bc-8888-81541c7504d3 -->","topic":{"id":"273ad47e-ae65-5768-be53-5ddd1a59479e","topicId":"bd5ef0a7-5bdf-453b-919f-23ebeade59e8","topicName":"Breast cancer - managing FH","slug":"breast-cancer-managing-fh","lastRevised":"Last revised in December 2018","chapters":[{"id":"f6ca27fc-9049-5932-b6b5-c6a1a14a77fd","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"2dd4a7a9-b879-5145-a15c-5922ac8e62ed","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"1eedf81f-6c36-5c24-816f-0c373b4fe0f4","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"f7449f3e-937f-584a-90af-48470e794a2c","slug":"changes","fullItemName":"Changes"},{"id":"28bea84b-3026-59d1-a564-3b8f8e660f19","slug":"update","fullItemName":"Update"}]},{"id":"d2268871-af9e-569e-ae6e-a786ab1bacec","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"c2ad0bbf-95fa-5512-a763-618d653b1f5e","slug":"goals","fullItemName":"Goals"},{"id":"b4ec1615-f118-573f-a98d-d4bbfdf7d53d","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"467c7316-a736-5600-b8e5-1c4ebf44b7ce","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"34c8a1ea-20f5-5197-86ff-6e75ed2a01c5","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"3361517e-9866-5a17-aabf-4d923a96c917","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"fdcd7c54-3a68-5903-a4a1-241a63d19e62","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"d7bd1803-d45e-508d-8661-62ebaa4b3353","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"c6831679-919f-5e59-b6b9-d09ed6486aca","slug":"definition","fullItemName":"Definition"},{"id":"7d6fa54b-1dc8-5cbd-9bf4-6d9ac0dc26f0","slug":"prevalence","fullItemName":"Prevalence"},{"id":"c5d1b518-b87d-58d6-8554-f3960af8f976","slug":"genetic-risk-factors","fullItemName":"Genetic risk factors"}]},{"id":"61970169-7827-5d9e-acb0-e40e0888525d","fullItemName":"Management","slug":"management","subChapters":[{"id":"b118c829-c5a1-5ee5-a8da-71eb67facd8d","slug":"breast-cancer-managing-fh","fullItemName":"Scenario: Breast cancer - managing FH"}]},{"id":"eaf7a93e-8dae-5737-ba9c-13e8ad484b3c","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"a9d84940-3c17-5039-b3f8-73ef73f06d13","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"a8dea3b7-f328-50ea-985f-2d54f906032c","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"067fe34b-66c2-52be-b2a6-f9366eaa8c2e","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"1f91e5ff-a2aa-5aaf-ac5c-67750822d1e8","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"0bfaeb6f-e800-5a87-a861-0d00aeb7c136","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"773a3929-781a-5faf-8d55-166112725d3a","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"89bfc412-56d8-52c5-95b1-6e923396679a","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"d7bd1803-d45e-508d-8661-62ebaa4b3353","slug":"background-information","fullItemName":"Background information"},"subChapters":[]}}},"staticQueryHashes":["3666801979"]}